Does the COMT Val108/158met Genotype Predict Cognitive Response to Antipsychotic Pharmacotherapy in Schizophrenia?

被引:0
|
作者
Khan, Anzalee [1 ,2 ]
Lindenmayer, Jean-Pierre [1 ,3 ]
Kaushik, Saurabh [4 ]
Mortensen, Daniel [1 ,5 ]
Thanju, Amod [1 ]
Michaels, Timothy [1 ]
Jit, Raminer [1 ]
McGurk, Susan [6 ]
机构
[1] Manhattan Psychiat Ctr, Psychopharmacol Res Program, Wards Isl, NY USA
[2] ProPhase LLC, Stat, New York, NY USA
[3] NYU, Sch Med, New York, NY USA
[4] St Josephs Hosp, Westchester, NY USA
[5] Columbia Univ, New York, NY USA
[6] Boston Univ, Boston, MA 02215 USA
关键词
COMT; Schizophrenia; Antipsychotics; Neurocognition;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
195
引用
收藏
页码:61S / 61S
页数:1
相关论文
共 50 条
  • [21] COMT Val108/158Met polymorphism effects DLPFC efficiency in healthy individuals
    Callicott, JH
    Egan, MF
    Goldberg, TE
    Dryden, EA
    Verchinski, BA
    Kolachana, B
    Fera, F
    Coppola, R
    Mattay, VS
    Weinberger, DR
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 105S - 105S
  • [22] Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine
    Porcelli, S.
    Bosia, M.
    Marino, E.
    Angelone, S. M.
    Smeraldi, E.
    Cavallaro, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S73 - S74
  • [23] Association between Catechol-O-Methyltrasferase Val108/158Met Genotype and Prefrontal Hemodynamic Response in Schizophrenia
    Takizawa, Ryu
    Tochigi, Mamoru
    Kawakubo, Yuki
    Marumo, Kohei
    Sasaki, Tsukasa
    Fukuda, Masato
    Kasai, Kiyoto
    PLOS ONE, 2009, 4 (05):
  • [24] The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults
    Ehrlich, Stefan
    Morrow, Eric M.
    Roffman, Joshua L.
    Wallace, Stuart R.
    Naylor, Melissa
    Bockholt, H. Jeremy
    Lundquist, Antonia
    Yendiki, Anastasia
    Ho, Beng-Choon
    White, Tonya
    Manoach, Dara S.
    Clark, Vincent P.
    Calhoun, Vince D.
    Gollub, Randy L.
    Holt, Daphne J.
    NEUROIMAGE, 2010, 53 (03) : 992 - 1000
  • [25] Association Study of COMT Val108/158met Polymorphism and Treatment Response to Cognitive Remediation Therapy in Patients Taking Benzodiazepine
    Khan, Anzalee
    Lindenmayer, Jean-Pierre
    Ljuri, Isidora
    Lachman, Herbert
    McGurk, Susan
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [26] Association between Val108/158 met polymorphism of the COMT gene and schizophrenia
    Wonodi, I
    Stine, OC
    Mitchell, BD
    Buchanan, RW
    Thaker, GK
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 120B (01) : 47 - 50
  • [27] The effect of COMT Val108/158Met Polymorphism on brain activations in response to negative affective facial stimuli
    Byung-Joo, H.
    In-Kwa, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S293 - S294
  • [28] Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia
    Roffman, Joshua L.
    Weiss, Anthony P.
    Deckersbach, Thilo
    Freudenreich, Oliver
    Henderson, David C.
    Wong, Donna H.
    Halsted, Charles H.
    Goff, Donald C.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2008, 147B (06) : 990 - 995
  • [29] Interactions between the COMT Val108/158Met polymorphism and maternal prenatal smoking predict aggressive behavior outcomes
    Brennan, Patricia A.
    Hammen, Constance
    Sylvers, Patrick
    Bor, William
    Najman, Jake
    Lind, Penelope
    Montgomery, Grant
    Smith, Alicia K.
    BIOLOGICAL PSYCHOLOGY, 2011, 87 (01) : 99 - 105
  • [30] Executive Attention in Schizophrenic Males and the Impact of COMT Val108/158Met Genotype on Performance on the Attention Network Test
    Opgen-Rhein, Carolin
    Neuhaus, Andres H.
    Urbanek, Carsten
    Hahn, Eric
    Sander, Thomas
    Dettling, Michael
    SCHIZOPHRENIA BULLETIN, 2008, 34 (06) : 1231 - 1239